Recent work demonstrated that matrix metalloproteinase 13 (MMP-13) serves as a critical osteoclastogenic factor that is highly expressed by human MM cells, thereby mediating MM-induced bone lesions3. This evidence concerns the gene MMP13 and Miyoshi myopathy.